Assessment of a shortened informed consent form for pediatric research: a pilot study

Peter D Murray1,2, Barbara E Bierer3,4, Steven Hirschfeld5

  • 1The Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA. PM7DN@hscmail.mcc.virginia.edu.

Pediatric Research
|July 4, 2018
PubMed

Insights

A simplified informed consent form (ICF) did not improve participant understanding of clinical trial components. Further comparison of shortened and conventional ICFs in actual trials is needed.

Area of Science:

  • Clinical Research
  • Human Participant Protection

Background:

  • The informed consent process is crucial in clinical research.
  • The informed consent form (ICF) is central to protecting human participants.

Purpose of the Study:

  • To evaluate if a shortened, simplified ICF with an appendix enhances participant understanding compared to a conventional ICF.
  • Assessing the impact of ICF simplification on comprehension of study details.

Main Methods:

  • Developed a shortened ICF from a conventional version for a neonatal study.
  • Randomly assigned either the shortened or conventional ICF to parental advocacy group members.
  • Collected participant feedback via surveys on their understanding and perception of the distributed ICF.

Main Results:

  • Higher participant satisfaction with the shortened ICF, with 76% finding it "short and to the point" versus 68% for the conventional ICF.
  • Despite perceived brevity, participants in the shortened ICF group indicated it lacked sufficient information.
  • No statistically significant differences were observed in the understanding of key study components between the two groups.

Conclusions:

  • A shortened informed consent form did not significantly alter participant comprehension of clinical trial information.
  • Future research should directly compare shortened and conventional ICFs within active clinical trials to validate these findings.
Abstract

Related Concept Videos

Pilot and Numeric Relaying01:21

Pilot and Numeric Relaying

Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
492
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237